Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1799711-21-9
Purity
95%
dBET1 is a hybrid molecule that combines (+)-JQ1 and thalidomide. dBET1 is a potent BRD4 protein inhibitor with an IC50 of 20 nM.
Properties
Name
dBET1
Smiles
CC1=NN=C2[C@H](CC(=O)NCCCCNC(=O)COC=3C=CC=C4C(=O)N(C5CCC(=O)NC5=O)C(=O)C43)N=C(C=6C(C)=C(C)SC6N12)C=7C=CC(Cl)=CC7
Targets
Please log in to see this information
SDS
dBET1
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$55
2 mg
$80
5 mg
$160
10 mg
$276
15 mg
$347
20 mg
$361
25 mg
$446
30 mg
$531
35 mg
$616
40 mg
$701
45 mg
$786
50 mg
$871
75 mg
$1274
100 mg
$POA
Quantity
1
Total amount
$ 160
dBET1
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.